P01-Pathogenesis and Prevention of Osteoporosis
P01-骨质疏松症的发病机制及预防
基本信息
- 批准号:6369226
- 负责人:
- 金额:$ 116.73万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:1987
- 资助国家:美国
- 起止时间:1987-09-30 至 2005-07-31
- 项目状态:已结题
- 来源:
- 关键词:
项目摘要
DESCRIPTION OF THE OVERALL PROGRAM (taken from the application): This program
project application represents a coordinated, collaborative and
multidisciplinary approach that utilizes common resources, facilities and
instrumentation to support scientific investigators related to the pathogenesis
of osteoporosis. This application is comprised of four highly integrated
scientific projects and three supporting core facilities (Administration,
Molecular Histology and Transgenic Animal and Molecular Cores). The central
theme of the ?program project is that the pathogenesis of osteoporosis is due
both to the interaction of catabolic factors that increase bone resorption and
to the loss of anabolic activities. These factors, both systemic hormones and
local cytokines, modulate the differentiation of osteoclast and osteoblast
lineage cells and the biological function of these cells. An understanding of
these factors and their actions on bone remodeling will help elucidate the
pathogenesis of osteoporosis. Moreover, intervention with molecules that block
pathogenic factors or enhance anabolic activities will have therapeutic
implications. This could be accomplished by somatic gene therapy once the
cellular and molecular steps required to develop such a strategy are developed.
The scientific projects of this application are: (1) Glucocorticoids and
osteoblast apoptosis, (2) Estrogen regulation of cytokine responsiveness in
bone: osteoclastogenesis, (3) The roles of insulin-like growth factor and
glucocorticoids on bone remodeling, and (4) Engraftment of osteoprogenitor
cells in bone. We believe that interactions among our investigators, research
productivity towards the central theme and new collaborations will be
facilitated greatly by the program project mechanism.
总体说明(取自应用程序):此程序
项目申请代表了一个协调,协作和
多学科方法,利用共同资源、设施和
支持与发病机制相关的科学研究者的仪器
骨质疏松症该应用程序由四个高度集成的
科学项目和三个支持核心设施(行政,
分子组织学和转基因动物和分子核心)。中央
的主题?骨质疏松症的发病机制是由于
既与增加骨吸收的分解代谢因子的相互作用有关,
合成代谢活动的丧失。这些因素,包括全身激素和
局部细胞因子,调节破骨细胞和成骨细胞的分化
谱系细胞和这些细胞的生物学功能。了解
这些因素及其对骨重建的作用将有助于阐明
骨质疏松症的发病机制。此外,用分子进行干预,
致病因素或增强合成代谢活动将有治疗
影响这可以通过体细胞基因治疗来完成,
开发了开发这种策略所需的细胞和分子步骤。
本次申请的科学项目为:(1)糖皮质激素和
成骨细胞凋亡,(2)雌激素调节细胞因子反应性,
骨:破骨细胞生成,(3)胰岛素样生长因子和
糖皮质激素对骨重建的影响;(4)骨祖细胞的移植
骨细胞我们相信,我们的调查人员之间的互动,研究
生产力对中心主题和新的合作将是
计划项目机制大大促进了这一进程。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
BARBARA E KREAM其他文献
BARBARA E KREAM的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('BARBARA E KREAM', 18)}}的其他基金
TRANSGENIC EXPRESSION OF 11B-HSD2 IN BONE
11B-HSD2 在骨中的转基因表达
- 批准号:
7002749 - 财政年份:2005
- 资助金额:
$ 116.73万 - 项目类别:
TRANSGENIC EXPRESSION OF 11B-HSD2 IN BONE
11B-HSD2 在骨中的转基因表达
- 批准号:
7354743 - 财政年份:2005
- 资助金额:
$ 116.73万 - 项目类别:
TRANSGENIC EXPRESSION OF 11B-HSD2 IN BONE
11B-HSD2 在骨中的转基因表达
- 批准号:
6873615 - 财政年份:2005
- 资助金额:
$ 116.73万 - 项目类别:
TRANSGENIC EXPRESSION OF 11B-HSD2 IN BONE
11B-HSD2 在骨中的转基因表达
- 批准号:
7169799 - 财政年份:2005
- 资助金额:
$ 116.73万 - 项目类别:
EFFECTS OF GLUCOCORTICOIDS AND IGF 1 ON BONE FORMATION
糖皮质激素和 IGF 1 对骨形成的影响
- 批准号:
6338654 - 财政年份:2000
- 资助金额:
$ 116.73万 - 项目类别:
相似海外基金
Virtual Mouse and Human Twins for optimising Treatments for Osteoporosis
虚拟小鼠和人类双胞胎用于优化骨质疏松症的治疗
- 批准号:
EP/Z000203/1 - 财政年份:2024
- 资助金额:
$ 116.73万 - 项目类别:
Research Grant
Optimizing osteoporosis diagnosis through opportunistic computed tomography: developing an implementation strategy for early detection and intervention.
通过机会性计算机断层扫描优化骨质疏松症诊断:制定早期检测和干预的实施策略。
- 批准号:
484646 - 财政年份:2023
- 资助金额:
$ 116.73万 - 项目类别:
Fellowship Programs
Center of Research Translation on Osteoporosis Bone Anabolic Therapies
骨质疏松症骨合成代谢疗法研究转化中心
- 批准号:
10404412 - 财政年份:2023
- 资助金额:
$ 116.73万 - 项目类别:
Optimizing Small Molecule Mechanomimetics to Treat Age-related Osteoporosis.
优化小分子力学模拟治疗与年龄相关的骨质疏松症。
- 批准号:
10807685 - 财政年份:2023
- 资助金额:
$ 116.73万 - 项目类别:
Leveraging a large cohort of patients with a unique, frequent renal sodium phosphate cotransporter, SLC34A3, pathogenic variation to understand and treat osteoporosis and kidney stones
利用大量具有独特、频繁的肾磷酸钠协同转运蛋白 SLC34A3 和致病变异的患者来了解和治疗骨质疏松症和肾结石
- 批准号:
494218 - 财政年份:2023
- 资助金额:
$ 116.73万 - 项目类别:
Operating Grants
Exploring therapeutic effects of anti-inflammatory and resolving factors in osteoporosis model mice
探讨抗炎和缓解因子对骨质疏松模型小鼠的治疗作用
- 批准号:
23K15705 - 财政年份:2023
- 资助金额:
$ 116.73万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Earlier identification and enhanced characterisation/quantification of Osteoporosis and Rheumatoid Arthritis for Clinics/MIU/ED/CDCs [“DT-RHU”]
诊所/MIU/ED/CDC 的骨质疏松症和类风湿关节炎的早期识别和增强表征/量化 [âDT-RHUâ]
- 批准号:
10068051 - 财政年份:2023
- 资助金额:
$ 116.73万 - 项目类别:
Collaborative R&D
Prevention of osteoporosis through early monitoring of multiple measures of bone health in one device
通过在一台设备中早期监测多种骨骼健康指标来预防骨质疏松症
- 批准号:
EP/X000958/1 - 财政年份:2023
- 资助金额:
$ 116.73万 - 项目类别:
Research Grant
Functional analysis of bone macrophages that control bone metabolism for the development of therapeutic drugs for osteoporosis.
控制骨代谢的骨巨噬细胞的功能分析,用于开发骨质疏松症治疗药物。
- 批准号:
23H03025 - 财政年份:2023
- 资助金额:
$ 116.73万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
Elucidating the role of NAD+ metabolism in osteoporosis
阐明 NAD 代谢在骨质疏松症中的作用
- 批准号:
23K19447 - 财政年份:2023
- 资助金额:
$ 116.73万 - 项目类别:
Grant-in-Aid for Research Activity Start-up